Canadian patients should verify supplier credentials, confirm independent third-party testing (not just supplier-conducted tests), ensure proper storage conditions during shipping (especially important given Canadian temperature extremes), and understand reconstitution protocols completely before use
Given the high disease burden of NASH and limited therapeutic options currently available, the FDA has proposed an accelerated pathway for drug approval
The obesity pharmacotherapy space continues to evolve with additional therapies in the pipeline including maritide (a GLP-1RA/GIP antagonist), cagrisema (a GLP-1RA/amylin RA), and retatrutide (a GLP-1RA /GIP/glucagon RA) which have shown promise in clinical trials [76]
PT-141 PT-141, also known as Bremelanotide, is a synthetic peptide developed from the peptide hormone Melanotan II
Are GLP-1 program Safe
3840 Magnesium is widely viewed by the public as an essential treatment for RLS, but a recent well-conducted systematic review found no conclusive evidence to support its widespread use by the public
